Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 751714, 7 pages
http://dx.doi.org/10.1155/2015/751714

Research Article

Hypocholesterolemic and Antiatherosclerotic Potential of Basella alba Leaf Extract in Hypercholesterolemia-Induced Rabbits

Gunasekaran Baskaran,¹ Shamala Salvamani,¹ Azrina Azlan,² Siti Aqlima Ahmad,¹ Swee Keong Yeap,³ and Mohd Yunus Shukor¹

¹Department of Biochemistry, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia
²Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia
³Institute of Bioscience, Universiti Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia

Received 14 May 2015; Accepted 11 November 2015

Academic Editor: Dolores García Giménez

Copyright © 2015 Gunasekaran Baskaran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Hypercholesterolemia is the major risk factor that leads to atherosclerosis. Nowadays, alternative treatment using medicinal plants gained much attention since the usage of statins leads to adverse health effects, especially liver and muscle toxicity. This study was designed to investigate the hypocholesterolemic and antiatherosclerotic effects of Basella alba (B. alba) using hypercholesterolemia-induced rabbits. Twenty New Zealand white rabbits were divided into 5 groups and fed with varying diets: normal diet, 2% high cholesterol diet (HCD), 2% HCD + 10 mg/kg simvastatin, 2% HCD + 100 mg/kg B. alba extract, and 2% HCD + 200 mg/kg B. alba extract, respectively. The treatment with B. alba extract significantly lowered the levels of total cholesterol, LDL, and triglycerides and increased HDL and antioxidant enzymes (SOD and GPx) levels. The elevated levels of liver enzymes (AST and ALT) and creatine kinase were noted in hypercholesterolemic and statin treated groups indicating liver and muscle injuries. Treatment with B. alba extract also significantly suppressed the aortic plaque formation and reduced the intima: media ratio as observed in simvastatin-treated group. This is the first in vivo study on B. alba that suggests its potential as an alternative therapeutic agent for hypercholesterolemia and atherosclerosis.

1. Introduction

Hypercholesterolemia is closely associated with atherosclerosis, which is the principal cause of mortality in world population. Hypercholesterolemia is characterized by increased serum concentrations of low-density lipoprotein (LDL) and triglycerides (TG) [1]. Accumulation of oxidized LDL leads to atherosclerotic plaque formation which contributes to stroke, myocardial infarction, and cardiovascular diseases (CVDs) [2]. It is well known that the hypocholesterolemic drugs are effective in lowering LDL but the long term consumption causes adverse effects such as liver and muscle injuries, rhabdomyolysis, myopathy, and acute renal failure. Thus, the investigation and usage of natural products from plant origin in treating various diseases including CVDs have gained much attention [3, 4].

The potential of medicinal plants that exhibit hypocholesterolemic and antiartherosclerotic effects is still largely unexplored and could be an effective and safe alternative strategy for the treatment of hypercholesterolemia. In previous study, we have screened the HMG CoA reductase inhibitory activity of 25 medicinal plants extracts. Basella alba (B. alba) extract showed the highest enzyme inhibition, about 74% [5].

B. alba is known as Indian spinach and Remayung locally and belongs to the family of Basellaceae. B. alba is a wildly cultivated vegetable that has been used from ancient time due to its various pharmacological activities such as antifungal, antiulcer, anticonvulsant, antihypertensive, and many more activities [6]. In Asian countries, the stem and leaf of B. alba have been employed as traditional medicine to treat dysentery, skin diseases, hemorrhages, anemia, constipation, gonorrhea, and cancer [7–9].

There are no in vivo reports on the effects of B. alba on hypercholesterolemia up to date. Therefore, the present study was aimed at investigating the hypocholesterolemic and antiatherosclerotic properties of B. alba in hypercholesterolemic rabbits and also at determining the antioxidant capacity of this extract.

2. Materials and Methods

2.1. Preparation of B. alba Methanol Extract

B. alba leaf was purchased from a local market in Seri Kembangan, Selangor, Malaysia. A voucher specimen was deposited in the Institute of Bioscience, Universiti Putra Malaysia (voucher number SK 2087/12). B. alba leaf was washed thoroughly and air-dried at room temperature for overnight. The leaf was grounded using a blender (MX 8967, Panasonic) and subjected to methanol 50% (v/v) distillation for 48 hours. After filtration, the leaf extract was isolated using a separatory funnel. The crude methanolic extract of B. alba was concentrated using rotary evaporator (Heidolph) under reduced pressure at 40°C and freeze-dried at −40°C for further analysis.

2.2. Animals and Experimental Design

Twenty male New Zealand white rabbits weighing 1.5–1.8 kg were purchased from local supplier. The animal studies were performed according to guidelines approved by the Institutional Animal Care and Use Committee (IACUC) of Universiti Putra Malaysia (UPM/IACUC/AUP-R011/2013). The rabbits were placed individually in stainless steel cages and were fed standard rabbit pellets for 1 week for acclimatization. Throughout the study, all the rabbits were kept in a 12 h light-dark cycle room with almost constant temperature at 23–25°C.

The in vivo study was carried out for 12 weeks. The rabbits were randomly divided into 5 groups (): Group 1: control rabbits fed with standard diet for 12 weeks; Group 2: rabbits fed with 2% high cholesterol diet (HCD) for 12 weeks; Group 3: rabbits fed with 2% HCD for 8 weeks and treatment with simvastatin (10 mg/kg) for 4 weeks; Group 4: rabbits fed with 2% HCD for 8 weeks and treatment with B. alba extract (100 mg/kg) for 4 weeks; and Group 5: rabbits fed with 2% HCD for 8 weeks and treatment with B. alba extract (200 mg/kg) for 4 weeks.

The high cholesterol diet was prepared by dissolving 2% cholesterol (USP grade, anhydrous; Sigma Chemical Co., Missouri, USA) in 99% chloroform and sprayed on standard pellets. Butylated hydroxyanisole (0.02% of diet) was dissolved in chloroform to reduce oxidation of cholesterol. The chloroform was evaporated by exposing the diets in well-ventilated fume hoods at room temperature for overnight. The diets were vacuum-packed and stored in −20°C freezer. All the rabbits received about 150 g pellets per day, with or without cholesterol supplementation, and water was provided ad libitum. Food and water consumption were recorded daily, while the body weight was measured every 2 weeks. Blood samples were collected at 0, 4, 8, and 12th week via ear marginal vein using 23-gauge butterfly needle and 3 mL syringes into EDTA and heparinised tubes. At the end of the study, the rabbits were euthanized with overdose of sodium pentobarbital through intravenous injection.

2.3. Measurement of Serum Lipids

Serum total cholesterol (TC), LDL, HDL, and triglycerides (TG) levels were determined using Roche kit (Penzberg, Germany) and measured spectrophotometrically using Hitachi chemistry analyzer (Tokyo, Japan).

2.4. Liver and Muscle Test

The serum levels of ALT, AST, and creatine kinase (CK) were evaluated by enzymatic kit (Randox Laboratories, Crumlin, UK) using Hitachi chemistry analyzer (Tokyo, Japan).

2.5. Antioxidant Activities

Superoxide Dismutase (SOD) activity was measured by RANSOD kit (Randox Laboratories, Crumlin, UK) using Vitalab Selectra Analyzer (Merck, Darmstadt, Germany). The collected erythrocytes were washed four times with NaCl solution (0.9%, 3 mL) by centrifugation at 1000 ×g for 10 min. Cold distilled water was added up to 2 mL to the packed erythrocytes, vortexed for 10 s, and incubated at 4°C for 15 min. The lysate was then diluted with phosphate buffer (pH 7, 0.01 mol/L) and mixed thoroughly. The absorbance of the mixture was determined at 505 nm. The Glutathione Peroxidase (GPx) activity was measured by diluting 0.05 mL serum with 2 mL of RANSEL kit diluting agent (Randox Laboratories, Crumlin, UK) and the mixture was read at 340 nm using Vitalab Selectra Analyzer (Merck, Darmstadt, Germany).

2.6. Histological Analysis

The aortic arch of the rabbits was removed, cleaned, dried, and fixed in 10% neutral buffer formalin. The tissues were embedded in paraffin, cut in 5 μm sections, and stained with hematoxylin and eosin. The atherosclerotic lesion was analyzed for the thickness of intima, media, and intima: media ratio of 4 rabbits per group under a light microscope equipped with image analyzer system (Olympus, Germany).

2.7. Statistical Analysis

The data obtained are expressed as mean ± SD. All groups were analyzed using SPSS program version 19.0. One-way analysis of variance (ANOVA) followed by Dunnett’s post hoc test for multiple comparisons among the groups was performed. The difference between groups was considered to be statistically significant when .

3. Results

3.1. Effect of B. alba Extract on Body Weight

In Table 1, rabbits fed with 2% cholesterol diet for 12 weeks showed significant increase () in body weight compared to the normal control. Treatment with simvastatin and B. alba (100 and 200 mg/kg) for 4 weeks managed to reduce the body weight compared to the untreated hypercholesterolemic rabbits.

Table 1: Changes on body weight of rabbits between different groups.

Group
Body weight (kg)

Initial
Final
Change

G1
1.61 ± 0.16
2.22 ± 0.09
0.61 ± 0.13

G2
1.65 ± 0.17
2.55 ± 0.13
0.90 ± 0.06

G3
1.63 ± 0.10
2.31 ± 0.14
0.68 ± 0.08

G4
1.75 ± 0.15
2.48 ± 0.13
0.73 ± 0.10

G5
1.84 ± 0.06
2.54 ± 0.16
0.70 ± 0.19

G1: normal control, G2: hypercholesterolemic control, G3: simvastatin-treated (10 mg/kg), G4: B. alba extract-treated (100 mg/kg), and G5: B. alba extract-treated (200 mg/kg). All data are presented as the mean ± SD ( for each group). Significantly different from others ( < 0.05).

3.2. Effect of B. alba Extract on Serum Lipid Profile

As shown in Table 2, serum levels of TC, LDL, and TG were significantly higher () in rabbits fed with HCD compared to the normal diet group after 8 weeks. There were significant decreases () in the level of TC, LDL, and TG at week 12, after 4 weeks of treatment with simvastatin and B. alba extract. Administration with 10 mg/kg of simvastatin, used as a positive control, significantly decreased 58.9, 51.1, and 40.9% in TC, LDL, and TG levels, respectively. Administration of B. alba at 100 and 200 mg/kg decreased TC level by 49 and 54.2%, respectively, LDL level by 45 and 50.1%, respectively, and TG level by 34.9 and 39.7%, respectively. The TC, LDL, and TG lowering effects of B. alba (200 mg/kg) were not significantly different with simvastatin. B. alba at dose of 200 mg/kg has significantly higher hypocholesterolemic effect than that of 100 mg/kg. Meanwhile, the HDL level of hypercholesterolemic control rabbits was significantly lower () compared to the normal control and treatment groups at week 12. Treatment with simvastatin and B. alba (100 and 200 mg/kg) showed significant increase () in HDL levels, 31.7, 39.6, and 53.4%, respectively. B. alba (200 mg/kg) increases the HDL level more effectively than simvastatin.

Table 2: Levels of total cholesterol, LDL, triglycerides, and HDL in serum of rabbits from various groups.

G1
G2
G3
G4
G5

Total cholesterol (mg/dL)

    Baseline
39.45 ± 2.95
39.33 ± 3.38
44.37 ± 3.87
41.41 ± 4.58
42.30 ± 4.33

    Week 4
42.66 ± 2.67
472.65 ± 4.54
480.83 ± 5.18
506.92 ± 9.57
467.08 ± 8.35

    Week 8
46.14 ± 4.06
1104.98 ± 33.32
1112.70 ± 28.33
1002.53 ± 11.51
1038.85 ± 12.35

    Week 12
53.57 ± 2.70
1326.91 ± 19.47
456.56 ± 5.23
510.99 ± 8.14
475.12 ± 10.94

LDL level (mg/dL)

    Baseline
26.48 ± 0.72
31.19 ± 0.97
25.39 ± 0.43
29.02 ± 1.13
27.03 ± 0.82

    Week 4
33.92 ± 0.55
426.15 ± 4.52
440.66 ± 3.39
421.68 ± 3.95
435.94 ± 2.57

    Week 8
38.79 ± 0.77
1157.09 ± 13.85
1056.66 ± 15.38
1001.23 ± 12.40
1081.04 ± 4.06

    Week 12
45.96 ± 1.01
1259.60 ± 15.43
515.83 ± 14.03
547.39 ± 12.81
539.27 ± 13.05

Triglyceride level (mg/dL)

    Baseline
110.13 ± 4.55
116.46 ± 3.68
106.88 ± 6.28
114.39 ± 5.36
107.56 ± 7.58

    Week 4
132.83 ± 7.84
340.63 ± 8.74
331.84 ± 4.97
349.42 ± 3.41
329.74 ± 6.95

    Week 8
156.38 ± 8.80
654.58 ± 15.16
650.96 ± 18.35
639.52 ± 16.04
661.12 ± 18.81

    Week 12
166.03 ± 5.81
869.57 ± 15.38
384.30 ± 14.63
416.14 ± 16.73
398.53 ± 10.66

HDL level (mg/dL)

    Baseline
45.65 ± 0.758
41.53 ± 5.27
38.27 ± 0.71
46.02 ± 1.15
39.83 ± 5.30

    Week 4
46.94 ± 1.09
38.13 ± 5.28
37.30 ± 0.78
44.31 ± 1.10
37.09 ± 5.27

    Week 8
47.45 ± 1.15
34.33 ± 5.18
36.37 ± 2.66
38.51 ± 3.35
35.88 ± 3.92

    Week 12
47.25 ± 0.45
28.27 ± 7.21
47.93 ± 2.51
53.78 ± 3.45
55.05 ± 1.26

G1: normal control, G2: hypercholesterolemic control, G3: simvastatin-treated (10 mg/kg), G4: B. alba extract-treated (100 mg/kg), and G5: B. alba extract-treated (200 mg/kg). All data are presented as the mean ± SD ( for each group). One-way ANOVA was performed followed by Dunnett’s post hoc test for multiple comparisons. Within a week, values sharing the same superscript letters are not significantly different from each other ( < 0.05).

3.3. Evaluation of Liver and Muscle Injuries

The hypercholesterolemia-induced rabbits showed significant increase () in ALT, AST, and CK levels as presented in Table 3. The results revealed that the treatment with B. alba extract (100 and 200 mg/kg) significantly decreased () ALT (40.5 and 44.9%, resp.), AST (37.3 and 43.7%, resp.), and CK (24.2 and 22.8%, resp.) levels while the treatment with simvastatin (10 mg/kg) showed significant elevation () in the levels of ALT (61.4%), AST (64.1%), and CK (34%).

Table 3: Levels of ALT, AST, and CK in serum of rabbits from various groups.

G1
G2
G3
G4
G5

ALT (U/L)

    Baseline
21.22 ± 1.27
20.30 ± 1.47
23.20 ± 1.37
21.43 ± 1.53
22.45 ± 0.75

    Week 4
21.05 ± 2.79
43.10 ± 4.67
47.75 ± 1.79
44.85 ± 1.44
46.18 ± 0.51

    Week 8
24.62 ± 1.65
63.75 ± 3.48
64.98 ± 6.99
67.85 ± 1.36
69.75 ± 1.48

    Week 12
29.15 ± 1.07
91.80 ± 4.45
104.85 ± 4.53
40.35 ± 2.24
38.43 ± 2.28

AST (U/L)

    Baseline
29.65 ± 1.23
29.65 ± 4.06
28.18 ± 3.86
25.93 ± 3.15
27.13 ± 4.16

    Week 4
32.97 ± 3.78
49.75 ± 8.63
51.78 ± 6.57
47.68 ± 5.57
46.33 ± 1.33

    Week 8
36.97 ± 1.09
67.48 ± 8.76
69.30 ± 8.17
67.65 ± 5.64
71.65 ± 2.84

    Week 12
39.87 ± 2.37
95.77 ± 8.54
113.75 ± 4.46
42.38 ± 3.46
40.32 ± 4.00

CK (U/L)

    Baseline
540.30 ± 22.85
578.80 ± 20.72
556.23 ± 51.60
544.08 ± 35.39
569.30 ± 36.96

    Week 4
555.50 ± 25.17
900.48 ± 75.95
886.55 ± 113.73
865.90 ± 88.06
881.45 ± 6.00

    Week 8
579.02 ± 22.00
1466.00 ± 233.42
1562.13 ± 196.69
1325.28 ± 97.91
1362.88 ± 104.08

    Week 12
597.80 ± 13.49
1931.48 ± 223.55
2093.95 ± 272.50
1004.30 ± 100.27
1051.03 ± 99.88

G1: normal control, G2: hypercholesterolemic control, G3: simvastatin-treated (10 mg/kg), G4: B. alba extract-treated (100 mg/kg), and G5: B. alba extract-treated (200 mg/kg). All data are presented as the mean ± SD ( for each group). One-way ANOVA was performed followed by Dunnett’s post hoc test for multiple comparisons. Within a week, values sharing the same superscript letters are not significantly different from each other ( < 0.05).

3.4. Evaluation of Serum Antioxidant Levels

As shown in Table 4, the hypercholesterolemic control showed significant reduction () in the levels of SOD and GPx throughout the study. B. alba-treated rabbits (100 and 200 mg/kg) caused significant increase () in SOD by 5 and 5.4%, respectively, and GPx by 15 and 21%, respectively. Meanwhile, simvastatin-treated groups showed significant reduction () in SOD and GPx, 4 and 19%, respectively.

Table 4: Levels of antioxidant enzymes in serum of rabbits from various groups.

G1
G2
G3
G4
G5

SOD (U/mL)

    Baseline
5.88 ± 0.17
5.63 ± 0.25
5.93 ± 0.11
5.72 ± 0.15
5.84 ± 0.12

    Week 4
5.98 ± 0.21
5.49 ± 0.34
5.61 ± 0.18
5.39 ± 0.30
5.33 ± 0.21

    Week 8
6.05 ± 0.22
5.35 ± 0.29
5.25 ± 0.25
4.96 ± 0.17
5.10 ± 0.31

    Week 12
6.20 ± 0.18
4.91 ± 0.20
5.04 ± 0.28
5.21 ± 0.73
5.38 ± 0.35

GPx (U/L)

    Baseline
1243.73 ± 91.21
1211.65 ± 101.19
1443.10 ± 55.78
1313.95 ± 232.95
1401.20 ± 171.33

    Week 4
1330.85 ± 77.53
1198.58 ± 90.38
1351.83 ± 128.17
1277.18 ± 184.68
1274.78 ± 124.44

    Week 8
1459.45 ± 175.80
1055.30 ± 62.23
1205.00 ± 82.15
1079.55 ± 213.70
1169.20 ± 82.50

    Week 12
1595.35 ± 219.20
885.23 ± 43.84
975.53 ± 62.41
1241.63 ± 181.98
1418.5 ± 82.55

G1: normal control, G2: hypercholesterolemic control, G3: simvastatin-treated (10 mg/kg), G4: B. alba extract-treated (100 mg/kg), and G5: B. alba extract-treated (200 mg/kg). All data are presented as the mean ± SD ( for each group). One-way ANOVA was performed followed by Dunnett’s post hoc test for multiple comparisons. Within a week, values sharing the same superscript letters are not significantly different from each other ( < 0.05).

3.5. Effect of B. alba Extract on Atherosclerotic Lesion

The atherosclerotic changes in aortic intimal surface of 5 groups are shown in Figure 1. Normal control group (G1) showed healthy aorta with uniform thickness and intact endothelial lining. On the other hand, hypercholesterolemic control group (G2) caused alteration in the aortic wall with the appearance of a large atheromatous plaque and demonstrated a remarkable intimal thickening of aorta. In contrast, treatment with simvastatin (G3) and B. alba (G4 and G5) revealed significant decrease in the thickening of intima and no plaques were detected in the aortic walls. Table 5 summarizes the thickness of intima, media, and intima/media ratio of the 5 groups at week 12. The hypercholesterolemic control group showed significant difference () with the highest value of intima and media thickness and intima/media ratio compared to other groups. On the other hand, significant reductions () were noted in the thickness of intima and media as well as intima/media ratio of simvastatin and B. alba (100 and 200 mg/kg) treated groups compared to the hypercholesterolemic control group. There was no significant difference () in the intima/media ratio between simvastatin and B. alba (200 mg/kg) treated groups.

Table 5: Thickness of intima, media, and intima/media ratio of experimental rabbits at week 12.

Groups
Intima thickness (µm)
Media thickness (µm)
Intima/media

G1
1045.439 ± 80.26
3350.768 ± 213.40
0.312 ± 0.039

G2
4203.296 ± 160.96
6004.708 ± 102.28
0.700 ± 0.023

G3
1585.270 ± 111.40
3809.198 ± 160.44
0.416 ± 0.035

G4
1786.301 ± 104.59
3978.398 ± 85.94
0.449 ± 0.019

G5
1720.678 ± 152.25
4058.203 ± 181.25
0.424 ± 0.033

G1: normal control, G2: hypercholesterolemic control, G3: simvastatin-treated (10 mg/kg), G4: B. alba extract-treated (100 mg/kg), and G5: B. alba extract-treated (200 mg/kg). All data are presented as the mean ± SD ( for each group). One-way ANOVA was performed followed by Dunnett’s post hoc test for multiple comparisons. Within a column, values sharing the same superscript letters are not significantly different from each other ( < 0.05).

Figure 1: Representative photographs of rabbits’ aortic arch from 5 groups stained with H&E. The aorta of a control hypercholesterolemic rabbit (G2) showing a large intimal plaque (arrow). G1: normal control, G2: hypercholesterolemic control, G3: simvastatin (10 mg/kg) treated, G4: B. alba extract (100 mg/kg) treated, and G5: B. alba extract (200 mg/kg) treated (Magnification 50x).

4. Discussion

This is the first report that demonstrates the oral administration of B. alba extract in hypercholesterolemia-induced rabbits. Rabbit is a good model to study hypercholesterolemia and atherosclerosis since its lipoprotein profile and metabolism are more similar to humans than that of rat or mouse [10]. In the present study, simvastatin, a potent hypocholesterolemic drug, was used as a positive control because it has known mechanism of action in inhibiting HMG-CoA reductase [11].

HCD feeding showed significant elevation of TC, LDL, and TG, which increase lipid peroxidation and influence the development of atherosclerosis, in agreement with several studies [12]. In contrast, a significant decrease noted in serum HDL in hypercholesterolemic rabbits was also reported by Ismail et al. [4]. The rabbits administered simvastatin or B. alba extract had reduction in body weight and serum levels of TC, LDL, and TG and significant increase noted in HDL levels.

LDL cholesterol is a primary target of atherosclerosis risk-reduction therapy. Excess LDL is mostly deposited in arterial wall and becomes a main component of atherosclerotic plaque formation, while HCD feeding has been reported to reduce fatty acid oxidation, resulting in the increase of serum TG which is considered as another risk factor for CVDs [13]. In our study, B. alba extract (100 and 200 mg/kg) elicited beneficial effects by attenuating the level of cholesterol including LDL and TG of the treated rabbits. B. alba extract (200 mg/kg) reduces TC, LDL, and TG levels as effectively as simvastatin.

HDL plays an essential role in protecting the membranes against oxidative damage. HDL is involved in the uptake and transport of cholesterol to the liver through reverse cholesterol transport process [14]. Epidemiological and clinical studies have shown that low level of HDL plays a crucial role in the atherogenic process [15]; thus, therapeutic approach to increase the HDL level is widely encouraged [16]. Significant increase in HDL as shown in B. alba-treated rabbits is a desirable criterion for an ideal hypercholesterolemic agent since it reduces the atherosclerotic risk.

The liver is the primary organ that is responsible for maintaining the cholesterol homeostasis. The marker enzymes, ALT and AST, were evaluated to detect the liver damage while CK was used to diagnose the muscle injury. These enzymes were reported to leak into the blood circulation when their cell membranes were injured [17]. The levels of the enzymes were found elevated in hypercholesterolemic control and simvastatin-treated rabbits compared to the normal group. This suggests high concentration of cholesterol and the usage of simvastatin caused liver and muscle damage [18, 19], whereas administration of B. alba extract for 4 weeks reduced the elevations of ALT, AST, and CK indicating its hepatic and muscle-protective effects.

Antioxidant enzymes (SOD and GPx) play essential roles in maintaining the physiological concentrations of oxygen and hydrogen peroxide by improving the dismutation of oxygen radicals [20]. A decrease in the level of SOD and GPx was observed in simvastatin-treated and hypercholesterolemic control groups. A significant decrease in GPx activity in simvastatin-treated group was also noted by Trocha et al. [21]; this could be due to the reduced antioxidant capacity in the serum of the animal model.

High cholesterol diet alters the in vivo antioxidant status in blood by increasing the oxygen free radicals that cause lipid peroxidation [22]. In our present study, feeding hypercholesterolemic diet for 8 weeks leads to the reduction in the activities of SOD and GPx. Many reports have also proved that hypercholesterolemia diminishes the activity of SOD [23, 24] and GPx [25]. The reduced level of SOD and GPx activities is associated with increased risk of CVD [26, 27]. The data obtained in this study suggested that B. alba extract is capable of enhancing the activity of SOD and GPx in hypercholesterolemia-induced rabbits; the effect could be due to the presence of phenolic compounds. Indeed, plant polyphenols have been reported to regulate antioxidative status by ameliorating the activity of antioxidant enzymes [20]. Therefore, this suggests that B. alba extract is capable of improving the antioxidant status and could be beneficial in managing oxidative damage and preventing lipid peroxidation.

Oxidized LDL molecules are commonly found in subendothelial layers. The accumulation of oxidized LDL in macrophages can stimulate proliferation of monocytes, smooth muscle cells, and endothelial cells. When the scavenging receptor for oxidized LDL on macrophages is upregulated, it leads to foam cells formation which are the major component of fatty streaks. This contributes to atheromatous plaque formation and thickening of intimal layer [28, 29]. The histopathological examination of aorta correlates with the serum biochemical data. The level of hypercholesterolemia was directly proportional with the severity of atherosclerotic plaque as observed in the aorta of hypercholesterolemic control group. Simvastatin and B. alba-treated rabbits revealed a significant reduction in aortic plaque and intimal thickening. In general, B. alba treatment (200 mg/kg) showed no significant difference in intima/media ratio compared to simvastatin-treated group. This suggests that B. alba extract (200 mg/kg) is as effective as simvastatin in treating atherosclerosis.

The mechanism by which B. alba inhibits the atherosclerotic plaque is not known but may be due to its antioxidant, hypocholesterolemic, and antiatherosclerotic effects such as decreasing oxidative stress, lowering the LDL level, reducing inflammation, and inhibiting macrophage accumulation. From the results obtained, it can be concluded that B. alba possesses therapeutic effects in treating hypercholesterolemia and atherosclerosis.

5. Conclusion

B. alba leaf extract could be an effective alternative treatment for hypercholesterolemia and atherosclerosis. The results from the present study showed that B. alba extract (200 mg/kg) effectively reduces the levels of TC, LDL, and TG and raised the level of HDL and antioxidants enzymes. B. alba leaf extract did not cause liver and muscle damage indicating that it is safe for consumption. B. alba successfully inhibited the atherosclerotic plaque formation in hypercholesterolemia-induced model. The finding from in vivo study is in good agreement with that of in vitro study with HMG CoA reductase, confirming the cholesterol lowering effect of B. alba. Further investigations are needed on the mechanisms of B. alba in inhibiting the atherosclerotic plaque formation. Isolation and identification of bioactive compounds of B. alba that are responsible for the observed effects are needed, which can be developed as a prophylactic agent against hypercholesterolemia and atherosclerosis.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

This research is supported by University Putra Malaysia, Grant no. 9399800. Baskaran Gunasekaran is supported by Ministry of Education (MOE) of Malaysia.

References

T. Yokozawa, E. J. Cho, S. Sasaki, A. Satoh, T. Okamoto, and Y. Sei, “The protective role of Chinese prescription Kangen-karyu extract on diet-induced hypercholesterolemia in rats,” Biological and Pharmaceutical Bulletin, vol. 29, no. 4, pp. 760–765, 2006.

S. K. Yeap, B. K. Beh, W. Y. Ho et al., “In vivo antioxidant and hypolipidemic effects of fermented mung bean on hypercholesterolemic mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 508029, 6 pages, 2015.

S. Salvamani, B. Gunasekaran, N. A. Shaharuddin, S. A. Ahmad, and M. Y. Shukor, “Antiartherosclerotic effects of plant flavonoids,” BioMed Research International, vol. 2014, Article ID 480258, 11 pages, 2014.

M. F. Ismail, M. Z. Gad, and M. A. Hamdy, “Study of the hypolipidemic properties of pectin, garlic and ginseng in hypercholesterolemic rabbits,” Pharmacological Research, vol. 39, no. 2, pp. 157–166, 1999.

G. Baskaran, S. Salvamani, S. A. Ahmad, N. A. Shaharuddin, P. D. Pattiram, and M. Y. Shukor, “HMG-CoA reductase inhibitory activity and phytocomponent investigation of Basella alba leaf extract as a treatment for hypercholesterolemia,” Drug Design, Development and Therapy, vol. 9, pp. 509–517, 2015.

R. Adhikari, K. H. Naveen, and S. Shruthi, “A review on medicinal importance of Basella alba L,” International Journal of Pharmaceutical Sciences and Drug Research, vol. 4, no. 2, pp. 110–114, 2012.

P. Kumar, “Indian spinach, Basella alba (PUI) succulent, branched, smooth, twining herbaceous vine,” in Best Nutrition, PR Log-Global Press Release Distribution, 2010.

H. Yasmin, M. A. Kaisar, M. M. R. Sarker, M. S. Rahman, and M. A. Rashid, “Preliminary anti-bacterial activity of some indigenous plants of Bangladesh,” Dhaka University Journal of Pharmaceutical Sciences, vol. 8, no. 1, pp. 61–65, 2009.

P. Balachandran and R. Govindarajan, “Cancer—an ayurvedic perspective,” Pharmacological Research, vol. 51, no. 1, pp. 19–30, 2005.

A. B. Waqar, T. Koike, Y. Yu et al., “High-fat diet without excess calories induces metabolic disorders and enhances atherosclerosis in rabbits,” Atherosclerosis, vol. 213, no. 1, pp. 148–155, 2010.

Y. Kureishi, Z. Luo, I. Shiojima et al., “The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals,” Nature Medicine, vol. 6, no. 9, pp. 1004–1010, 2000.

Y. Zhang, L. Li, J. You, J. Cao, X. Fu, and Y. Zhang, “Effect of 7-difluoromethyl-5, 4′-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE−/− mice induced by a cholesterol-rich diet,” Development Theraphy, vol. 7, pp. 233–242, 2013.

O. A. Adaramoye, V. O. Nwaneri, K. C. Anyanwo, E. O. Farombi, and G. O. Emerole, “Possible anti-atherogenic effect of kolaviron (a Garcinia kola seed extract) in hypercholesterolaemic rats,” Clinical and Experimental Pharmacology and Physiology, vol. 32, no. 1-2, pp. 40–46, 2005.

J.-R. Nofer, B. Kehrel, M. Fobker, B. Levkau, G. Assmann, and A. V. Eckardstein, “HDL and arteriosclerosis: beyond reverse cholesterol transport,” Atherosclerosis, vol. 161, no. 1, pp. 1–16, 2002.

G. Assmann and A. M. Gotto Jr., “HDL cholesterol and protective factors in atherosclerosis,” Circulation, vol. 109, no. 23, supplement 1, pp. 111–118, 2004.

O. A. Adaramoye, O. Akintayo, J. Achem, and M. A. Fafunso, “Lipid-lowering effects of methanolic extract of Vernonia amygdalina leaves in rats fed on high cholesterol diet,” Vascular Health & Risk Management, vol. 4, no. 1, pp. 235–241, 2008.

F. Martinello, S. M. Soares, J. J. Franco et al., “Hypolipemic and antioxidant activities from Tamarindus indica L. pulp fruit extract in hypercholesterolemic hamsters,” Food and Chemical Toxicology, vol. 44, no. 6, pp. 810–818, 2006.

S. Bolkent, R. Yanardag, S. Bolkent, and M. M. Döger, “Beneficial effects of combined treatment with niacin and chromium on the liver of hyperlipemic rats,” Biological Trace Element Research, vol. 101, no. 3, pp. 219–229, 2004.

R. S. Scott, C. J. Lintott, and M. J. Wilson, “Simvastatin and side effects,” New Zealand Medical Journal, vol. 104, no. 924, pp. 493–495, 1991.

M. I. Kazeem, M. A. Akanji, M. T. Yakubu, and A. O. T. Ashafa, “Protective effect of free and bound polyphenol extracts from ginger (Zingiber officinale Roscoe) on the hepatic antioxidant and some carbohydrate metabolizing enzymes of streptozotocin-induced diabetic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 935486, 7 pages, 2013.

M. Trocha, A. Merwid-Lad, E. Chlebda, M. Pieśniewska, T. Sozański, and A. Szelag, “Effect of simvastatin treatment on rat livers subjected to ischemia/reperfusion,” Pharmacological Reports, vol. 62, no. 4, pp. 757–762, 2010.

K. Prasad and J. Kalra, “Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E,” American Heart Journal, vol. 125, no. 4, pp. 958–973, 1993.

M. A. Mikail, I. A. Ahmed, M. Ibrahim et al., “Baccaurea angulata fruit inhibits lipid peroxidation and induces the increase in antioxidant enzyme activities,” European Journal of Nutrition, pp. 1–10, 2015.

I. Fki, M. Bouaziz, Z. Sahnoun, and S. Sayadi, “Hypocholesterolemic effects of phenolic-rich extracts of Chemlali olive cultivar in rats fed a cholesterol-rich diet,” Bioorganic and Medicinal Chemistry, vol. 13, no. 18, pp. 5362–5370, 2005.

J. Balkan, S. Doğru-Abbasoğlu, G. Aykaç-Toker, and M. Uysal, “The effect of a high cholesterol diet on lipids and oxidative stress in plasma, liver and aorta of rabbits and rats,” Nutrition Research, vol. 24, no. 3, pp. 229–234, 2004.

A. Crawford, R. G. Fassett, D. P. Geraghty et al., “Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease,” Gene, vol. 501, no. 2, pp. 89–103, 2012.

B. Buijsse, D.-H. Lee, L. Steffen et al., “Low serum glutathione peroxidase activity is associated with increased cardiovascular mortality in individuals with low HDLc's,” PLoS ONE, vol. 7, no. 6, Article ID e38901, 2012.

L. Yao, J. E. Heubi, D. D. Buckley et al., “Separation of micelles and vesicles within lumenal aspirates from healthy humans: solubilization of cholesterol after a meal,” Journal of Lipid Research, vol. 43, no. 4, pp. 654–660, 2002.

V. M. Homer, A. D. Marais, F. Charlton et al., “Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa,” Atherosclerosis, vol. 196, no. 2, pp. 659–666, 2008.